School of Clinical and Experimental Medicine, College of Medical and Dental Sciences, Institute of Biomedical Research, University of Birmingham, Edgbaston, Birmingham, West Midlands B15 2TT, UK.
Mol Cell Endocrinol. 2010 Jun 30;322(1-2):135-43. doi: 10.1016/j.mce.2010.01.013. Epub 2010 Jan 18.
Graves' disease (GD) and Hashimoto's thyroiditis (HT) make up the autoimmune thyroid diseases (AITD), with classical clinical characteristics arising as a result of environmental factors in people who are genetically predisposed. Three gene regions consistently associated with AITD include the Human Leucocyte Antigen (HLA) region, CTLA4 and PTPN22, which represent general autoimmune risk loci and encode molecules vital for correct immune system function. AITD patients in addition are likely to carry at least one thyroid specific susceptibility locus. Recent genetic studies have refined association of the TSHR with GD to within a 40kb region including intron 1, of the TSHR itself, with preliminary evidence to suggest altered mRNA isoform expression. These findings, combined with previous functional data demonstrating that the TSHR A-subunit is the primary autoantigenic region, suggests novel mechanisms for the onset of GD and a potential therapeutic target.
格雷夫斯病(GD)和桥本甲状腺炎(HT)构成了自身免疫性甲状腺疾病(AITD),其典型的临床特征是由于遗传易感性人群中的环境因素引起的。与 AITD 相关的三个基因区域包括人类白细胞抗原(HLA)区域、CTLA4 和 PTPN22,它们代表了一般的自身免疫风险基因座,并编码对免疫系统正常功能至关重要的分子。AITD 患者还可能携带至少一个甲状腺特异性易感性基因座。最近的遗传研究已经将 TSHR 与 GD 的关联细化到 TSHR 自身内含子 1 内的 40kb 区域,初步证据表明 mRNA 同工型表达发生改变。这些发现,结合以前的功能数据表明 TSHR A 亚基是主要的自身抗原区域,提示了 GD 发病的新机制和潜在的治疗靶点。